[HTML][HTML] Impact of reduced-dose nonvitamin K antagonist oral anticoagulants on outcomes compared to warfarin in Korean patients with atrial fibrillation: a nationwide …

S Han, YH Kim, MY Lee, OY Bang, SW Jang… - Journal of Clinical …, 2021 - mdpi.com
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of reduced-dose nonvitamin k antagonist oral anticoagulants on outcomes compared to warfarin in korean patients with atrial fibrillation: A nationwide …

S Han, YH Kim, MY Lee, OY Bang… - Journal of Clinical …, 2021 - khu.elsevierpure.com
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide …

S Han, YH Kim, MY Lee, OY Bang, SW Jang, S Han… - 2021 - kumel.medlib.dsmc.or.kr
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide …

S Han, YH Kim, MY Lee, OY Bang… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide …

S Han, YH Kim, MY Lee, OY Bang… - Journal of Clinical …, 2021 - europepmc.org
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

[HTML][HTML] Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A …

S Han, YH Kim, MY Lee, OY Bang… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide …

S Han, YH Kim, MY Lee, OY Bang… - JOURNAL OF …, 2021 - scholar.korea.ac.kr
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of reduced-dose nonvitamin k antagonist oral anticoagulants on outcomes compared to warfarin in korean patients with atrial fibrillation: A nationwide …

S Han, YH Kim, MY Lee, OY Bang… - Journal of Clinical …, 2021 - scholarworks.bwise.kr
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide …

H Sola, K Young-Hoon, L Myung-Yong… - Journal of Clinical …, 2021 - search.proquest.com
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide …

S Han, YH Kim, MY Lee, OY Bang… - Journal of Clinical …, 2021 - search.ebscohost.com
Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …